These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3132386)

  • 21. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
    Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
    Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
    [No Abstract]   [Full Text] [Related]  

  • 22. Antifungal combinations against Candida albicans biofilms in vitro.
    Bachmann SP; Ramage G; VandeWalle K; Patterson TF; Wickes BL; López-Ribot JL
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3657-9. PubMed ID: 14576141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of cilofungin (LY 121019) in combination with amphotericin B or flucytosine against Candida species.
    Bulo AN; Bradley SF; Kauffman CA
    Mycoses; 1989 Mar; 32(3):151-7. PubMed ID: 2733727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of cilofungin (LY 121019) in combination with amphotericin B or flucytosine against Candida species.
    Bulo AN; Bradley SF; Kauffman CA
    Mycoses; 1989 Jan; 32(1):46-52. PubMed ID: 2747742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
    Arikan S; Sancak B; Hascelik G
    Med Mycol; 2005 Mar; 43(2):171-8. PubMed ID: 15832560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
    Peter J; Armstrong D; Lyman CA; Walsh TJ
    J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species.
    Huang A; Edwards F; Bernard EM; Armstrong D; Schmitt HJ
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):697-9. PubMed ID: 2226501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.
    Ramage G; VandeWalle K; Bachmann SP; Wickes BL; López-Ribot JL
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3634-6. PubMed ID: 12384379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis.
    Müller FM; Kurzai O; Hacker J; Frosch M; Mühlschlegel F
    J Antimicrob Chemother; 2001 Nov; 48(5):713-5. PubMed ID: 11679561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
    Di Bonaventura G; Spedicato I; Picciani C; D'Antonio D; Piccolomini R
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4453-6. PubMed ID: 15504881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Tomassetti S; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4989-92. PubMed ID: 16304162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms.
    Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
    J Antimicrob Chemother; 2016 Sep; 71(9):2498-501. PubMed ID: 27147303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
    Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.